Update on Multiple Myeloma 2019
DOI: 10.5772/intechopen.81751
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Targets and Signaling Pathways for Diagnosis of Myeloma

Abstract: Multiple myeloma (MM) is a malignancy of plasma cells that not only shows different clinical behavior but also depicts heterogeneous groups at molecular level. The prognosis of the disease has been dramatically changed with the arrival of new drugs in the past few years. In this context of better therapeutic agents, there are important challenges for accurate evaluation of patients by better prognostic and predictive tools. Transcriptomic studies have largely added to decipher MM heterogeneity, dividing MM pat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 143 publications
(221 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?